Locations:
January 12, 2026/Florida - Local

Cleveland Clinic Florida Names Chad R. Ritch, M.D., Chair of the Division of Urology

In his new role, Dr. Ritch will lead efforts to expand clinical excellence, enhance resident education, foster innovation, and strengthen academic and research initiatives across Cleveland Clinic’s Florida market

Media Contact

Cleveland Clinic News Service | 216.444.0141

We’re available to shoot custom interviews & b-roll for media outlets upon request.

Media Downloads

CCNS health and medical content is consumer-friendly, professional broadcast quality (available in HD), and available to media outlets each day.

Chad R. Ritch, M.D.

Chad R. Ritch, M.D., MBA, FACS, has been named chair of the Division of Urology for the Cleveland Clinic Florida market, effective January 2026.

Dr. Ritch is a nationally recognized urologic oncologist who has dedicated his career to advancing clinical care, research and education in urology. His expertise encompasses bladder, prostate and kidney cancer, with a focus on robotic surgery.

Prior to joining Cleveland Clinic, Dr. Ritch served as professor of urology and director of the Society of Urologic Oncology fellowship program at the University of Miami Miller School of Medicine in Miami. He has authored more than 150 peer-reviewed publications, book chapters and scientific presentations, served as principal investigator on numerous clinical trials, and played a pivotal role in pioneering the single-port robotic surgical system in South Florida. Dr. Ritch was also the associate director for University of Miami international patient services and led the expansion of the health system’s global footprint.

Dr. Ritch earned his medical degree and MBA from the University of Chicago. He completed his urology residency at Columbia University in New York City, followed by a urologic oncology fellowship at Vanderbilt University in Nashville.

In his new role, Dr. Ritch will lead efforts to expand clinical excellence, enhance resident education, foster innovation, and strengthen academic and research initiatives across Cleveland Clinic’s Florida market.

“We are thrilled to welcome Dr. Ritch to our leadership team,” said F. Scott Ross, M.D., Vice President and Chief Medical Officer of Cleveland Clinic Weston Hospital. “His exceptional experience as a clinician, educator and researcher will further elevate the quality and innovation of our urology program.”

About the Cleveland Clinic Florida Region

Cleveland Clinic’s regional health system in Florida is a nonprofit, multispecialty healthcare provider integrating clinical and hospital care with research and education. The Florida region includes Cleveland Clinic Weston Hospital, Cleveland Clinic Indian River Hospital and Cleveland Clinic Martin Health, with five hospitals and numerous outpatient centers across Broward, Palm Beach, Martin, St. Lucie and Indian River counties.

The Florida region is an integral part of Cleveland Clinic in Ohio, where providing outstanding patient care is based on cooperation, compassion and innovation. Physicians at Cleveland Clinic are experts in treating complex conditions that are difficult to diagnose.

For more information about Cleveland Clinic in Florida, visit www.clevelandclinicflorida.org. Follow us on X, LinkedIn, Instagram and Facebook.

Latest from the Newsroom

Photo of scale wit a tape measure.

Cleveland Clinic Study Identifies Best Treatment Strategies for Weight Loss After Stopping GLP-1 Drugs

Cleveland Clinic's new teaching kitchen and food pantry at the Langston Hughes Community Health & Education Center

Cleveland Clinic Opens Teaching Kitchen and Food Pantry on Cleveland's East Side

VeloSano riders

$20.2 Million Raised for VeloSano, Funding Cancer Research at Cleveland Clinic in 2026

Photo of spine imaging.

Cleveland Clinic Expands Orthopaedic Care in the Mahoning Valley Through Acquisition of Youngstown Orthopaedic Associates Practice

Lobby of new Toronto location

Cleveland Clinic Canada Moves to New Downtown Toronto Location

Artist's rendering of gene therapy for high triglycerides.

Gene Editing Therapy Trial Dramatically Lowers Dangerous Blood Fat Levels

Artist's illustration of gene editing

Cleveland Clinic First-in-Human Trial Shows Gene-Silencing Therapy for High Cholesterol to Be Safe and Effective

Medical illustration of lipoprotein(a) molecule

Cleveland Clinic Trial Shows Novel Lipoprotein(a) Drug Did Not Reduce Major Cardiovascular Events After Nearly 5 Years